Fredrik Gunnarson Email

Analytisk kemist . Iconovo

Current Roles

Employees:
51
Revenue:
$10.3M
About
ICONOVO AB is developing proprietary inhalation products for licensing. We have long experience and track record in the development of dry powder inhalers and offer a comprehensive range of devices to our clients. Our selection of device concepts for dry powder inhalation include a reservoir inhaler, a pre-metered inhaler, a capsule based inhaler and a single dose disposable inhaler. We can also provide formulation development, performance testing, documentation and a complete supply-chain.
Iconovo Address
Medicon Village
Lund, null

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.